{"transactions":[{"id":3952312,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":167130,"kind":"person","name":"Shabtai Gilad","position":1,"cik":"0001726027","reported_name":"Shabtai Gilad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-01T20:39:38.000Z","date":"2018-04-30","kind":"purchase","acquired":true,"shares":75000,"price":9.75,"value":731250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the purchase of shares in the follow-on offering of Common Stock of Eloxx Pharmaceuticals, Inc. that closed on April 30, 2018."}],"balance_after":3351770,"source":{"system":"sec-edgar","filing":"0001209191-18-027116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118027116/doc4.xml","form_type":"4"}},{"id":3968599,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":167130,"kind":"person","name":"Shabtai Gilad","position":1,"cik":"0001726027","reported_name":"Shabtai Gilad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-05T22:08:59.000Z","date":"2018-04-04","kind":"purchase","acquired":true,"shares":2600,"price":9.58,"value":24908.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.69666, inclusive."}],"balance_after":3276770,"source":{"system":"sec-edgar","filing":"0001209191-18-024125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118024125/doc4.xml","form_type":"4"}},{"id":3968598,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":167130,"kind":"person","name":"Shabtai Gilad","position":1,"cik":"0001726027","reported_name":"Shabtai Gilad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-05T22:08:59.000Z","date":"2018-04-03","kind":"purchase","acquired":true,"shares":5700,"price":9.41,"value":53637.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.413, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":3274170,"source":{"system":"sec-edgar","filing":"0001209191-18-024125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118024125/doc4.xml","form_type":"4"}},{"id":3977194,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":167130,"kind":"person","name":"Shabtai Gilad","position":1,"cik":"0001726027","reported_name":"Shabtai Gilad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T21:43:37.000Z","date":"2018-03-29","kind":"purchase","acquired":true,"shares":4500,"price":9.64,"value":43380.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.63 to $9.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":3268470,"source":{"system":"sec-edgar","filing":"0001209191-18-022544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118022544/doc4.xml","form_type":"4"}}]}